<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2623">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04583033</url>
  </required_header>
  <id_info>
    <org_study_id>20201031</org_study_id>
    <nct_id>NCT04583033</nct_id>
  </id_info>
  <brief_title>Sleep Well for Healthy Brain</brief_title>
  <official_title>Lifestyle Stressors of Hippocampus and Alzheimer's Disease (AD) Related Brain Regions: Potential for Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Florida Department of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to slow down the aging of the participant's brain by improving&#xD;
      sleep quality.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 28, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of brain tissue volume loss in specific brain regions</measure>
    <time_frame>Year 2</time_frame>
    <description>As evaluated from the Magnetic Resonance Imaging (MRI) Brain scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive Performance</measure>
    <time_frame>Year 2</time_frame>
    <description>Cognitive performance will be assessed using a Memory test which has a composite score ranging from 80 to 120 % with a higher score indicating better performance and a midrange at 100%.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Poor Quality Sleep</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy (CBT) Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive CBT intervention bi-weekly for total of six (6) sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will not receive any intervention as part of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy (CBT)</intervention_name>
    <description>Treatment components include stimulus control, sleep restriction therapy, relaxation, and cognitive therapy. Each session will last approximately one hour and will be provided on line.</description>
    <arm_group_label>Cognitive Behavioral Therapy (CBT) Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English-speaking healthy subjects age 55 years and older capable and willing to&#xD;
             consent to participate in the study. In addition, subject should be cognitively normal&#xD;
             and have well documented sleep issues that results with poor sleep quality based on&#xD;
             self-reported assessment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  cognitively impaired subjects not able to provide consent&#xD;
&#xD;
          -  prisoners&#xD;
&#xD;
          -  Subjects 55 years of age and older that meet criteria for mild cognitive impairment.&#xD;
&#xD;
          -  Subjects with any neurological disorder.&#xD;
&#xD;
          -  Any other condition that in the opinion of the investigator may affect the&#xD;
             participation in this study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noam Alperin</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clara I. Morales</last_name>
    <phone>305-243-3404</phone>
    <email>c.morales1@miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sang Lee</last_name>
    <phone>305-243-6559</phone>
    <email>lsang2@miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clara I Morales</last_name>
      <phone>305-243-3404</phone>
      <email>c.morales1@miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sang Lee</last_name>
      <phone>305-243-6559</phone>
      <email>lsang2@miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Noam Alperin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2022</verification_date>
  <study_first_submitted>October 6, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2020</study_first_posted>
  <last_update_submitted>September 28, 2022</last_update_submitted>
  <last_update_submitted_qc>September 28, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Noam Alperin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

